Abstract:CRISPR systems have been proven as versatile tools for site-specific genome engineering in mammalian species. During the gene editing processes, these RNA-guide nucleases introduce DNA double strand breaks (DSBs), in which non-homologous DNA end joining (NHEJ) dominates the DNA repair pathway, limiting the efficiency of homology-directed repair (HDR), the alternative pathway essential for precise gene targeting. Multiple approaches have been developed to enhance HDR, including chemical compound or RNA interference-mediated inhibition of NHEJ factors, small molecule activation of HDR enzymes, or cell cycle timed delivery of CRISPR complex. However, these approaches face multiple challenges, yet have moderate or variable effects. Here we developed a new approach that programs both NHEJ and HDR pathways with CRISPR activation and interference (CRISPRa/i) to achieve significantly enhanced HDR efficiency of CRISPR-mediated gene editing. The manipulation of NHEJ and HDR pathway components, such as CtIP, CDK1, KU70, KU80, and LIG4, was mediated by catalytically dead guide RNAs (dgRNAs), thus relying on only a single catalytically active Cas9 to perform both CRISPRa/i and precise gene editing. While reprogramming of most DNA repair factors or their combinations tested enhanced HDR efficiency, simultaneously activating CDK1 and repressing KU80 has the strongest effect with increased HDR rate upto an order of magnitude. Doxycycline-induced dgRNA-based CRISPRa/i programming of DNA repair enzymes, as well as viral packaging enabled flexible and tunable HDR enhancement for broader applicability in mammalian cells. Our study provides an effective, flexible, and potentially safer strategy to enhance precise genome modifications, which might broadly impact human gene editing and therapy.

CRISPR/Cas9‐Directed Genome Editing of Cultured Cells

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Genome engineering using the CRISPR-Cas9 system

Development and application of CRISPR/Cas9 technologies in genomic editing.

Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9

RNA-Guided Human Genome Engineering via Cas9

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells

CRISPR-Cas systems for editing, regulating and targeting genomes

CRISPER/CAS: A potential tool for genomes editing

Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis

CRISPR-Cas9: A Precise Approach to Genome Engineering

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos

Multiplex Genome Engineering Using CRISPR/Cas Systems

The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells

CRISPR/Cas9 in Genome Editing and Beyond

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

Computationally guided high-throughput engineering of an anti-CRISPR protein for precise genome editing in human cells